The Neuroimmunology of Cancer

作者: Enrico C. Lallana , William F. Hickey , Camilo E. Fadul

DOI: 10.1007/978-1-60327-860-7_13

关键词: Primary tumorImmunologyGliomaTumor microenvironmentMedicineImmune systemAutoimmune ProcessNervous systemImmunotherapyNeuroimmunology

摘要: Decreased immune surveillance is thought to be one of the mechanisms by which neoplastic cells are able thrive. When cancer located in nervous system, an privileged site, its ability evade detection, and targeting may contribute aggressive behavior. Furthermore, high-grade gliomas, most frequent lethal primary brain tumors, induce both a local systemic state suppression that hampers efforts manipulate system as effective therapeutic modality. On other hand, there rare instances when response elucidated against causes injury without direct spread tumor. Although neural mediated autoimmune process, cases it uncertain if caused humoral response, cellular or combination both. This chapter reviews concepts related unique relationship between systems, present, well modalities employed structures affected directly tumor indirectly case paraneoplastic neurologic syndromes. The distinct immunologic characteristics central (CNS) become more complex setting disease. In 2008, approximately 1,437,180 new cases, including 21,810 arising from were diagnosed USA [1]. Gliomas, type characterized infiltration normal cerebral tissue, but this rarely results metastases. microenvironment shows meager inflammatory often accompanied suppression. These alterations might considered epiphenomena unrelated pathogenesis, experimental clinical observations suggest plays important role glioma biology. Our current concept immunobiology lends strong support idea manipulating approach for tumors. Glioma immunotherapy has evolved over years, unfortunately yet, major success. Nevertheless, extraneural neoplasms can trigger have repercussions system. interactions cause syndromes aptly termed some antibodies been identified element responsible phenomenon, tumors spinal cord, pathogenesis these not clearly elucidated.

参考文章(162)
M. Stephen Mahaley, William H. Brooks, Thomas L. Roszman, Darell D. Bigner, Lynn Dudka, Sheila Richardson, Immunobiology of primary intracranial tumors. Part 1: studies of the cellular and humoral general immune competence of brain-tumor patients. Journal of Neurosurgery. ,vol. 46, pp. 467- 476 ,(1977) , 10.3171/JNS.1977.46.4.0467
Andrew W. Taylor, J. Wayne Streilein, Inhibition of antigen-stimulated effector T cells by human cerebrospinal fluid. Neuroimmunomodulation. ,vol. 3, pp. 112- 118 ,(1996) , 10.1159/000097235
Sean J Pittock, Claudia F Lucchinetti, Inflammatory transverse myelitis: evolving concepts. Current Opinion in Neurology. ,vol. 19, pp. 362- 368 ,(2006) , 10.1097/01.WCO.0000236615.59215.D3
J. H. MD, H. K. MS, M. K. Rosenblum, J. B. Posner, Paraneoplastic cerebellar degeneration. II. Clinical and immunologic findings in 21 patients with Hodgkin's disease. Neurology. ,vol. 42, pp. 1938- 1938 ,(1992) , 10.1212/WNL.42.10.1938
T. M. Burns, V. C. Juel, D. B. Sanders, L. H. Phillips, Neuroendocrine lung tumors and disorders of the neuromuscular junction. Neurology. ,vol. 52, pp. 1490- 1490 ,(1999) , 10.1212/WNL.52.7.1490
A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, T. Murray, M. J. Thun, Cancer statistics, 2008. CA: A Cancer Journal for Clinicians. ,vol. 58, pp. 71- 96 ,(2008) , 10.3322/CA.2007.0010
M. L. Rossi, J. T. Hughes, M. M. Esiri, H. B. Coakham, D. B. Brownell, Immunohistological study of mononuclear cell infiltrate in malignant gliomas Acta Neuropathologica. ,vol. 74, pp. 269- 277 ,(1987) , 10.1007/BF00688191
William H. Brooks, Martin G. Netsky, David E. Normansell, David A. Horwitz, Depressed cell-mediated immunity in patients with primary intracranial tumors. Characterization of a humoral immunosuppressive factor. Journal of Experimental Medicine. ,vol. 136, pp. 1631- 1647 ,(1972) , 10.1084/JEM.136.6.1631
Berta Jereb, Jelka Petrič, Janez Lamovec, Miha Škrbec, Evgen Šošš, Intratumor Application of Human Leukocyte Interferon-α in Patients with Malignant Brain Tumors American Journal of Clinical Oncology. ,vol. 12, pp. 1- 7 ,(1989) , 10.1097/00000421-198902000-00001
Gentao Liu, Yasuharu Akasaki, Hung T Khong, Christopher J Wheeler, Asha Das, Keith L Black, John S Yu, Cytotoxic T cell targeting of TRP-2 sensitizes human malignant glioma to chemotherapy Oncogene. ,vol. 24, pp. 5226- 5234 ,(2005) , 10.1038/SJ.ONC.1208519